184 related articles for article (PubMed ID: 18165847)
1. The amyloid cascade: the old and the new.
Marcello E; Epis R; Gardoni F; Di Luca M
J Nutr Health Aging; 2008 Jan; 12(1):58S-60S. PubMed ID: 18165847
[No Abstract] [Full Text] [Related]
2. Perspectives on the amyloid-beta cascade hypothesis.
Lee HG; Casadesus G; Zhu X; Joseph JA; Perry G; Smith MA
J Alzheimers Dis; 2004 Apr; 6(2):137-45. PubMed ID: 15096697
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of synaptic pathology in Alzheimer's disease.
Masliah E
J Neural Transm Suppl; 1998; 53():147-58. PubMed ID: 9700653
[TBL] [Abstract][Full Text] [Related]
4. The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease.
Gouras GK; Willén K; Faideau M
Neurodegener Dis; 2014; 13(2-3):142-6. PubMed ID: 24080821
[TBL] [Abstract][Full Text] [Related]
5. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
6. [Molecular neurobiology of Alzheimer amyloid protein precursor].
Yoshikawa K
Seikagaku; 1993 Sep; 65(9):1149-59. PubMed ID: 8270816
[No Abstract] [Full Text] [Related]
7. Mechanisms of neuronal degeneration in Alzheimer's disease.
Yankner BA
Neuron; 1996 May; 16(5):921-32. PubMed ID: 8630250
[No Abstract] [Full Text] [Related]
8. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
Castello MA; Soriano S
Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
[TBL] [Abstract][Full Text] [Related]
9. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
Saul A; Sprenger F; Bayer TA; Wirths O
Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
[TBL] [Abstract][Full Text] [Related]
10. Biochemistry of Alzheimer's disease amyloid plaques.
Fraser PE; Lévesque L; McLachlan DR
Clin Biochem; 1993 Oct; 26(5):339-49. PubMed ID: 8299204
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.
Koffie RM; Hashimoto T; Tai HC; Kay KR; Serrano-Pozo A; Joyner D; Hou S; Kopeikina KJ; Frosch MP; Lee VM; Holtzman DM; Hyman BT; Spires-Jones TL
Brain; 2012 Jul; 135(Pt 7):2155-68. PubMed ID: 22637583
[TBL] [Abstract][Full Text] [Related]
12. The role of cytosolic phospholipase A2 α in amyloid precursor protein induction by amyloid beta1-42 : implication for neurodegeneration.
Sagy-Bross C; Kasianov K; Solomonov Y; Braiman A; Friedman A; Hadad N; Levy R
J Neurochem; 2015 Mar; 132(5):559-71. PubMed ID: 25533654
[TBL] [Abstract][Full Text] [Related]
13. The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer's disease.
Wang YT; Ashton NJ; Servaes S; Nilsson J; Woo MS; Pascoal TA; Tissot C; Rahmouni N; Therriault J; Lussier F; Chamoun M; Gauthier S; Brinkmalm A; Zetterberg H; Blennow K; Rosa-Neto P; Benedet AL
Transl Neurodegener; 2024 May; 13(1):27. PubMed ID: 38802928
[No Abstract] [Full Text] [Related]
14. N-terminus truncated beta-amyloid peptides and C-terminus truncated secreted forms of amyloid precursor protein: distinct roles in the pathogenesis of Alzheimer's disease.
Geddes JW; Tekirian TL; Mattson MP
Neurobiol Aging; 1999; 20(1):75-9; discussion 87. PubMed ID: 10466897
[No Abstract] [Full Text] [Related]
15. Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia.
Jendroska K; Hoffmann OM; Patt S
Ann N Y Acad Sci; 1997 Sep; 826():401-5. PubMed ID: 9329712
[No Abstract] [Full Text] [Related]
16. [Alzheimer's disease and neuronal death].
Yanagisawa K
Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1712-6. PubMed ID: 10581751
[No Abstract] [Full Text] [Related]
17. Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease.
Richardson JC; Kendal CE; Anderson R; Priest F; Gower E; Soden P; Gray R; Topps S; Howlett DR; Lavender D; Clarke NJ; Barnes JC; Haworth R; Stewart MG; Rupniak HT
Neuroscience; 2003; 122(1):213-28. PubMed ID: 14596862
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death.
Leong YQ; Ng KY; Chye SM; Ling APK; Koh RY
Metab Brain Dis; 2020 Jan; 35(1):11-30. PubMed ID: 31811496
[TBL] [Abstract][Full Text] [Related]
19. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
20. A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss.
Cohen RM; Rezai-Zadeh K; Weitz TM; Rentsendorj A; Gate D; Spivak I; Bholat Y; Vasilevko V; Glabe CG; Breunig JJ; Rakic P; Davtyan H; Agadjanyan MG; Kepe V; Barrio JR; Bannykh S; Szekely CA; Pechnick RN; Town T
J Neurosci; 2013 Apr; 33(15):6245-56. PubMed ID: 23575824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
